Guidance for Industry: “Lookback” for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notific
BACKGROUND Lookback related to HCV testing has been discussed at open public meetings, including meetings of FDA’s Blood Products Advisory Committee (BPAC), on multiple occasions since October 1989. As a response to these discussions, FDA provided ......